glp 1 growth GLP-1 Antagonists Increase Plan Drug Spend - What's Next GLP-1 Market Size, Scope, Forecast

Description

PALO ALTO, Calif., September 28, 2023 (BUSINESS WIRE)-- Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced today the launch of its latest innovation in obesity care, Digbi GLP-Fit, a scientifically-backed approach to identify the best treatment path for an individual to prevent and treat obesity

Not only does this treatment failure burden the healthcare system with excess costs, it can also be devastating for patients who end up right back where they started

The study also included a sample size of 20, but it featured a treatment duration of 3 months

Alcohol sales also may drop as GLP-1 users lower their alcoholic beverage intake, PwC added, noting that 33% of habitually heavy drinkers in its survey reported reducing their alcohol consumption